Affinity Dependence of the B Cell Response to Antigen: A Threshold, a Ceiling, and the Importance of Off-Rate  by Batista, Facundo D & Neuberger, Michael S
Immunity, Vol. 8, 751±759, June, 1998, Copyright 1998 by Cell Press
Affinity Dependence of the B Cell Response
to Antigen: A Threshold, a Ceiling,
and the Importance of Off-Rate
receptor to survive selectively in the competitive envi-
ronment of the germinal center must be conferred by
the improved binding of its receptor to the antigenÐa
process that could be read out by either selective scav-
enging of the small amounts of available antigen, im-
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United Kingdom proved antigen-dependent signaling (leading to rescue
from apoptosis), or improved recruitment of T cell help
through more effective antigen presentation. Here, we
have sought to determine how the B cell response toSummary
antigen varies as a function of antigen/BCR interaction
affinity.Initiation and affinity maturation of the humoral im-
mune response is driven by antigen interaction with
BCR. To study how signaling and antigen presentation Results
through BCR depend on antigen/BCR affinity, lyso-
zyme-specific B cell transfectants were challenged Comparison of HEL Presentation
with mutated lysozymes differing in their binding kinet- through Different BCRs
ics. For detectable triggering, the antigen/BCR com- The antigen upon which we focus is hen egg lysozyme
plex needed a Ka . 106 M21 (dissociation half-life . (HEL) since it is essentially monomeric, thus facilitating
z1 s). Mutated lysozymes whose binding was below the measurements of antibody/antigen interaction kinet-
this threshold could nevertheless be presented if com- ics. Several monoclonal antibodies have been described
plexed with soluble antibody. Above the threshold, the that bind HEL with high affinity, three of which have
concentration of antigen required to trigger a response been shown to bind distinct epitopes on the surface of
decreased as the affinity (particularly dissociation the protein in a noncompetitive manner (Lavoie et al.,
half-life) increased. However, a plateau was reached 1989). We have largely focused on two of these antibod-
at Kas . z1010 M21 (dissociation half-life . 0.5 hr), ies: HyHEL10, which has an affinity of Ka 5 5 3 1010 M21
supporting the idea of a ceiling to affinity maturation. (Lavoie et al., 1992; Smith-Gill et al., 1982; Kam-Morgan
et al., 1993), and D1.3, which binds a nonoverlapping
epitope on HEL with the lower Ka of 3 3 108 M21 (MariuzzaIntroduction
et al., 1983; Amit et al., 1986; Tello et al., 1990; Foote
and Winter, 1992).The development of the humoral immune response is
We compared the ability of the HyHEL10 and D1.3characterized by affinity maturation (Jerne, 1951; Eisen
BCRs to mediate HEL presentation to T cell hybridomasand Siskind, 1964). On first encounter with a foreign
that are specific for HEL peptides in the context of MHCantigen, the B cells that recognize it are likely to bind it
class II. Transfectants were established of the mousewith low affinity. However, during proliferation in germi-
LK35.2 B cell lymphoma (H2kxd haplotype) that ex-nal centers the antigen-recruited B cells undergo a pe-
pressed IgM BCRs containing either HyHEL10 or D1.3riod of somatic hypermutation that gives rise to a small
VH/VL regions (Figure 1A). Presentation of HEL-derivedproportion of cells expressing high-affinity receptors.
epitopes to T cell hybridomas was then monitored byThese B cells expressing receptors of improved affinity
culturing the cells in the presence of various concentra-are selectively expanded in an antigen-mediated pro-
tions of HEL and measuring the IL-2 produced fromcess, giving rise to affinity maturation.
the T cells. The HyHEL10 transfectant is able to triggerWhilst the evidence for affinity maturation was origi-
activation of the 2G7 T cell hybridoma when cultured innally based on an analysis of the serum antibody elicited
the presence of 0.05 nM HEL; incontrast, concentrationsfollowing immunization, the development of monoclonal
of HEL of around 100 nM are required to trigger presen-antibodies has allowed a more detailed study of the
tation when taken up by fluid phase pinocytosis by theantigen binding properties of the antibodies produced
untransfected B cell host (Figure 1C). The D1.3 BCRby individual B lymphocytes selected during an ongoing
could also efficiently enhance presentation of this HELimmune response. Such studies have confirmed affinity
epitope but the concentration of antigen needed wasmaturation by somatic hypermutation to be a central
somewhat more than 10-fold higher than that requiredfeature of the developing response, except when the
by the HyHEL10 BCR. Similar results were obtained withprimary response is already of very high affinity (see
multiple independent clones of the B cell transfectantsreviews in MoÈ ller, 1987; Foote and Milstein, 1991; Foote
and when other T cell hybridomas were used for readoutand Eisen, 1995; Roost et al., 1995).
(Figure 1C).The process by which a small number of high-affinity
The difference between the HyHEL10 and D1.3 trans-binders are selectively amplified out of a sea of B cells
fectants in their ability to present low concentrations ofexpressing receptors of lower affinity is not understood
HEL is most straightforwardly attributable to a differencein detail. The ability of a B cell expressing a high-affinity
in the affinities of the two BCRs for the antigen. Support
for the importance of affinity is provided by comparing
the ability of the two BCRs to mediate presentation of*To whom correspondence should be addressed.
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Figure 1. Presentation of Wild-Type Lysozyme by HEL-Specific B Cell Transfectants
(A) Plasmids driving expression of HEL-specific IgM BCRs with VH/VL regions derived from either D1.3 or HyHEL10 antibodies. The mouse H
chain vector based on pSV2gpt potentiates expression of the mm (but not ms) isoform; the L-chain expression unit (which was inserted into
the unique EcoRI [R] site of the H chain vector) encodes a k light chain containing a rat C region. The VH and VL segments of D1.3 and HyHEL10
were PCR amplified and inserted between the SacI (S) and XhoI (X) or PstI (P) and BstEII (Bs) sites of these vectors as indicated. R, EcoRI.
(The vectors contain additional PstI and BstEII sites that are not indicated.)
(B) Expression of HEL-specific BCRs on the surface of transfectants of the LK35.2 B cell line. Transfectants were stained with PE-conjugated
goat anti-m and FITC-conjugated anti-rat k MAb (upper three panels) or with biotinylated HEL followed by PE-conjugated streptavidin or with
the E5.2 MAb (IgG1,k directed against a D1.3 idiotope [Goldbaum et al., 1994]) and FITC-conjugated anti-IgG1 (lower panels).
(C) Comparison of antigen presentation through D1.3 and HyHEL10 BCRs. Presentation by HyHEL10 and D1.3 transfectants of LK35.2 incubated
with various concentrations of HEL was monitored by measuring IL-2 production from the cocultured 2G7 T cell hybridoma (recognizing IEk/
HEL1±18). Presentation by HyHEL10 transfectants (boxes); by D1.3 transfectants (circles); presentation through fluid phase (rather than BCR-
mediated) uptake (triangles; Fl. Ph., monitored using untransfected LK35.2 cells). The same comparison of HEL presentation by the LK35.2
BCR transfectants was performed but using the 2B6 and 1E5 T cell hybridomas (recognizing IAk/HEL25±43 and IEd/HEL108±116, respectively) for
read-out. Similar results were obtained using the 3B11 T cell hybridomas (recognizing IAk/HEL34±45) as well as using multiple independent
cloned LK35.2 transfectants.
(D) Presentation of turkey egg lysozyme (TEL) by the B cell transfectants was monitored using the 1E5 T cell hybridoma.
turkey egg lysozyme (TEL). Whilst TEL contains many (Figure 2). A myeloma expression system was devised
for the production of the mutants. The concentration ofof the same T cell epitopes as HEL and is able to bind
HyHEL10 with high affinity, TEL has a drastically re- the recombinant HELs was then determined by using
the mutants to compete the binding of biotinylated wild-duced affinity for D1.3 (see Table 1). Whereas TEL was
presented well through the HyHEL10 BCR, the D1.3 type HEL to theHyHEL5 MAb since the HyHEL5antibody
recognizes a HEL epitope distant from the D1.3-bindingtransfectants presented it no better than their fluid
phase control (Figure 1D). site (Sheriff et al., 1987). The deduced concentrations
correlated well with the intensity of silver staining ob-
tained following analysis in SDS±PAGE.Presentation of HEL Mutants through the D1.3 BCR:
Evidence for an Affinity Threshold Analysis by competitive ELISA revealed that the Kas
of the I124 and V120 mutants for D1.3 had decreased 20-We wished to probe the effect of varying antigen/BCR
binding strength on the efficacy of presentation in more and 35-fold respectively compared to that of wild-type
HEL (Table 1). Surface plasmon resonance demon-detail. Rather than modify the BCR and compare presen-
tation by different B cell transfectants, we modified the strated that these decreased Kas were largely attribut-
able to a decreased half-life of the antigen/antibodyantigen and monitored the effect of individual amino
acid substitutions of HEL on its presentation through complexes rather than a decreased rate of association
(Figure 2D). In contrast to their diminished D1.3 binding,D1.3. To this end, we exploited the high-resolution struc-
ture of the HEL/D1.3 complex (Bhat et al., 1990) and the mutants showed essentially unaltered binding to
HyHEL10 as judged by both competition ELISA and sur-prepared HEL mutants in which individual D1.3 contact
residues (V120 and I124) had been substituted by alanines face plasmon resonance. Binding was also unaffected
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Table 1. Binding Constants of Mutant Lysozymes
Competition ELISA Surface Plasmon Resonance
[1/Karel] Ka 3 108 M21 T1/2 (min) [1/T1/2rel]
Binding to D1.3
HEL WT 1 3 3.8 1
I124 20 0.15 0.28 13
V120 35 0.08 0.14 27
R125 40 0.075 0.13 30
Q121 100 0.03 z0.04 z100
R21 1.8 1.6 2.3 2
TEL z400 z0.007 Ð Ð
Binding to HyHEL10
HEL WT 1 500 230 1
G102 1.5 330 140 1.6
D101 2 250 115 2
R21 4 125 58 4
R21, N103 4 125 58 4
R21, G102 5 100 28 8
R21, D101 12 42 12 17
R21, D101, G102, N103 100 5 1.4 150
The Ka values for the HEL/D1.3 and HEL/HyHEL10 complexes are taken from Foote and Winter, 1992, and Lavoie et al., 1992, respectively;
these values accord well with those deduced from our kinetic measurements made using the Biacore (which gives kon values of 1±2 3 106
M21s21 for D1.3 and 2±4 3 106 M21s21 for HyHEL10) as well, in the case of D1.3, with Ka estimates obtained by fluorescence quench and the
ELISA method of Friguet et al. (1985). Karel values, a measure of the relative affinity of a mutant HEL for the MAb expressed compared to that
of wild-type HEL, were deduced by competition ELISA and were used for calculation of Kas. The deduced Ka of TEL for D1.3 correlates well
with the value (8 3 105 M21) obtained by Neri et al. (1995) using the method of Friguet et al. (1985). Similarly, the Kas deduced for the R21/
HyHEL10 and D101/HyHEL10 complexes correlate well with the values obtained by Kam-Morgan et al. (1993) who independently made and
used the method of Friguet et al. (1985) to analyze analogous substitutions. Dissociation half-lives (T1¤2) were determined using the Biacore
at 258C and pH 7.4; repeat estimates were within 15% except for the Q121 mutant and TEL/D1.3 complexes, owing to their fast dissociation
rates.
to distinct HEL-specific MAb (F10) that recognizes a mutation was originally designed to create a modified
HEL with diminished HyHEL10 binding [see below] butregion on HEL overlapping the HyHEL5 binding site
(Schwarz et al., 1995). was fortuitously found also to exhibit diminished D1.3
binding.) Thus, not only is there a minimum thresholdBoth the V120 and I124 mutations led to a markeddiminu-
tion in antigen presentation through the D1.3 BCR (Fig- stability for the antigen/BCR complex in order to trigger
specific presentation, but presentation in the affinityure 3A). However, consistent with the fact that the bind-
ing of these mutants to HyHEL10 MAb is unaltered, range characteristic of D1.3 (an antibody isolated from
the secondary response to HEL) is still very sensitive topresentation through the HyHEL10 BCR was unaffected.
To extend the correlationbetween affinity and presen- the precise antigen/BCR binding kinetics.
tation and determine the threshold needed to trigger
specific presentation, we prepared additional HEL mu- Presentation of HEL Mutants through
the HyHEL10 BCR: Evidencetants carrying distinct changes in the D1.3-binding site.
Two of them (Q121 and R125) showed substantially de- for an Affinity Ceiling
We wished to extend the range of affinities studies socreased D1.3 binding (Table 1). However, specific pre-
sentation through the D1.3 BCR was still detectable, as to monitor the effect of varying antigen affinity within
the high-affinity range. To this end, we prepared a rangealthough the amount of Q121 mutant required to trigger
detectable BCR-mediated presentation was only some of HEL mutants that carried alanine substitutions in or
around the binding site for HyHEL10 (Table 1). Here,3-fold less than that required for fluid-phase presenta-
tion (Figure 3C). The Q121 and R125 mutants were unaltered decreasing dissociation T1¤2 from 230 min (the value for
wild-type HEL) through 140, 115, 58 down to 28 min hadwith respect to HyHEL10 and F10 binding (Figure 2) and
exhibited wild-type presentation through the HyHEL10 relatively little effect on presentation (Figure 4). How-
ever, efficacy of specific presentation fell dramaticallyBCR (not shown). The results indicate that the minimum
Ka for the lysozyme/D1.3 complex that is compatible at T1¤2 values , 12 min. These results were controlled
by monitoring presentation of these mutants throughthewith specific presentation must be in the range of 106
M21, corresponding to a dissociation half-life of about D1.3 BCR. All the HEL variants mutated in the HyHEL10-
binding site (except those carrying an alanine substitu-1 s. Indeed, TEL which has a Ka of 7 3 105 M21 (Table
1) is not detectably presented through D1.3 (Figure 1D). tion at position R21) were unaltered in respect of D1.3
binding and D1.3 BCR-mediated presentation (FigureEven at affinity values similar to that exhibited by D1.3
for wild-type HEL, presentation is still very sensitive to 4C). The data obtained with the HEL mutants exhibiting
diminished HyHEL10 binding point toward an affinityaffinity. Thus, the HEL R21 mutant that shows a reduction
in its dissociation half-life with D1.3 from 3.8 to 2.3 min plateau for presentation with relatively little benefit being
achieved by increasing the half-life of antigen/BCR dis-(Table 1) nevertheless gave significantly diminished pre-
sentation through the D1.3 BCR (Figure 3C). (This R21 sociation beyond about 30 min.
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Figure 2. Mutant Lysozymes
(A) Location of mutated HEL residues. The figure depicts the binding of three anti-HEL MAbs (only Fv portions shownÐunshaded) to HEL
(shaded). The coordinates are taken from the Brookhaven database. A magnification is used to illustrate the locations of the residues mutated
(in black).
(B) Analysis of recombinant HEL by SDS±PAGE.
(C) Binding inhibition assays. The ability of the mutant and wild-type HELs to compete the binding of biotinylated wild-type HEL to D1.3,
HyHEL10, and F10 MAbs bound to the plate was tested by ELISA. Symbols for wild-type HEL and individual mutants are as defined in Figure
3. Binding inhibition by the R21 mutant is shown only in the D1.3 ELISA panel.
(D) Surface plasmon resonance. Binding of the various HEL mutants to D1.3 or HyHEL10 antibody immobilized on a sensor chip was monitored
using a Biacore. In the case of D1.3, the surface resonance at individual times is plotted as the logarithm of the inverse ratio of the resonance
units at that time (RU) to the value at time zero (RU0) whereas for HyHEL10 (where the dissociation rate is far slowerÐnote the very slow
decrease in RU signal from times beyond 70 s), the results are plotted directly as RU values against time. The different curves in the HyHEL10
plots are not individually labeled as they reveal indistinguishable kinetics.
Complexing with Soluble Antibody Lowers of oligomerization, in this case complexing with soluble
HyHEL10 antibody, can even be used to obtain effectivethe Threshold but Does Not Raise
the Affinity Ceiling presentation of TEL through the D1.3 BCR (Figure 5B),
something which is otherwise undetectable, owing toThe results with the in vitro presentation assays point
to an affinity threshold for presentation in the order of Ka the poor binding of TEL to D1.3.
106 M21. However, in vivo, specific presentation through If, as proposed earlier, the sensitivity of presentation
BCR plays a role in the initiation of the antibody response of wild-type HEL by the D1.3BCR is limited by theaffinity
when the affinity of antigen/BCR interaction is likely to of the D1.3/HEL interaction whereas the sensitivity of
be low. One possibility is that presentation of low affinity HEL presentation through the HyHEL10 BCR is at the
antigen is enhanced in vivo through cross-linking with limits of sensitivity of the assay, then one would predict
serum immunoglobulin. Indeed, presentation of HEL that whereas D1.3-mediated presentation of wild-type
mutant [R21, D101, G102, N103]Ðwhich is normally very poor HEL could be augmented by complexing with soluble
through the HyHEL10 BCR, owing to the greatly dimin- antibody, HyHEL10-mediated presentation could not.
ished affinity of the antigen/BCR interactionÐis dramat- This is indeed the case (Figures 5B and 5C).
ically enhanced if the mutant HEL is complexed using
a soluble D1.3 antibody (Figure 5A). This enhancement
Affinity Dependence of BCR Signalingoccurs with both IgM and IgG isoforms of the soluble
In vivo responses to antigen depend upon the triggeringD1.3 antibody and also depends on the presence of
of BCR-mediated signaling cascades as well as on BCR-the BCR rather than reflecting Fc receptor-mediated
mediated presentation. In view of the fact that, in vivo,presentation since the effect is not observed with un-
transfected LK35.2 cells (Figure 5A). This same strategy the B cell is likely to be exposed to antigen over a
Affinity Dependence of the B Cell Response
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Figure 3. Presentation of HEL Mutants Exhibiting Diminished D1.3
Binding
(A and B) Presentation of V120 (T1¤2 0.14 min) and I124 (T1¤2 0.28 min) Figure 4. Presentation of HEL Mutants Exhibiting Diminished Hy-mutants through the D1.3 (A) and HyHEL10 BCRs (B). Presentation
HEL10 Bindingof wild-type HEL (WT; T1¤2 3.8 min) by the same cells (filled circles)
(A) HEL mutants were designed on the basis of the HEL/HyHEL10as well as by untransfected LK35.2 cells (filled triangles; Fl. Ph.,
crystal structure (Padlan et al., 1989) as well as mutational datafluid phase control) is included for comparison. Controls for fluid
of Kam-Morgan et al. (1993) and their rate of dissociation fromphase presentation of the mutant HELs are provided in a separate
immobilized HyHEL10 monitored by surface plasmon resonance.panel. The numbers given by each line are the dissociation half-life
The concentration of lysozyme passed over the chip was adjustedof the relevant lysozyme/D1.3 complex. Presentation was monitored
such that the relative stabilities of the different mutant/HyHEL10using the 2G7 T cell hybridoma.
complexes is easily visualized. The binding of the mutants to Hy-(C) Presentation of R21 (T1¤2 2.3 min), R125 (T1¤2 0.13 min), and Q121 (T1¤2
HEL10 was also monitored by competition ELISA as for the D1.3-0.04 min) mutants through the D1.3 BCR. Presentation in this case
binding mutants (not shown), and this forms the basis of the Karelwas monitored using the 1E5 T cell hybridoma. Each panel in this
values presented in Table 1.figure shows assays performed in a single batch but a similar hierar-
(B) Presentation of mutant lysozymes through the HyHEL10 BCRchy of presentation was observed when various combinations of
was monitored by culturing LK35.2[HyHEL10] transfectants with themutant HELs were compared using different T cell hybridomas (1E5,
2B6 T-cell hybridoma. The symbols for the mutant lysozymes are2G7, 2B6, F1.2, 4C1, and 3B11).
defined in the figure with ªTetraº designating the R21,G102,D101,N103
mutant. Presentation of wild-type HEL by the HyHEL10 transfectants
significant period of time, we exploited BCR-mediated (filled circles) as well as by untransfected LK35.2 cells (filled trian-
gles; fluid phase control) is included for comparison. Controls forIL-2 production by the A20 mouse B cell lymphoma in an
fluid phase presentation of the mutant HELs are provided in a panelantigen/B cell coculture system as our signaling assay.
on the right. The numbers given by each line are the dissociationLigation of the BCR in the A20 lymphoma (unlike in most
half-life of the relevant lysozyme/HyHEL10 complex. Similar results
other B cell lymphomas including the LK35.2 line used were obtained when presentation was read out using the 1E5, 2G7,
here) has been shown to trigger IL-2 production (Juste- and 3B11 T cell hybridomas.
ment et al., 1989). We established A20 transfectants (C) Presentation of these same mutants through the D1.3 BCR.
D1.3-mediated presentation is essentially unaltered except for thoseexpressing either the HyHEL10 or D1.3 BCRs and moni-
mutants containing an R21 substitution, which affects D1.3 bindingtored IL-2 production following exposure tovarious con-
(Table 1).centrations of the mutant HELs. The results (Figure 6)
indicate BCR-mediated signaling and antigen presenta-
tion exhibits a broadly similar dependence on affinity.
Immunity
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Figure 6. Signaling by HEL Mutants
Signaling was monitored by measuring the IL-2 production by A20 B
cell transfectants (top panel A20[D1.3]; lower panel A20 [HyHEL10])
incubated with the various mutant lysozymes (symbols as in Figures
3 and 4). The control curve (open triangles) presents IL-2 production
from untransfected A20 cells. The numbers given within the panels
refer to the dissociation T1¤2s of the various lysozyme/BCR com-
plexes. The signaling curve for the D101 mutant on the HyHEL10 BCR
(T1¤2 115 min) is not shown but overlaps the curve obtained with
wild-type HEL.
Figure 5. Complexing with Soluble Antibody Enhances Presenta-
tion of Low-Affinity Antigen values .1010 M21, a ceiling was reached such that further
(A) Presentation of HEL mutant [R21,G102,D101,N103] by LK[HyHEL10] increases in Ka did not lead to improved B cell triggering.
B cell transfectants (Mut) is enhanced by addition of soluble IgG or These conclusions were achieved with free antigen in
IgM D1.3 antibody to the assay (Mut 1 IgM/G). Presentation of wild-
circumstances that differ substantially to those per-type HEL (filled circles) and fluid phase presentation is shown for
taining to B cell selection in vivo. Nevertheless, we be-comparison (filled triangles). Presentation by untransfected LK35.2
lieve the conclusions to be broadly applicable to in vivocells of mutant HEL alone or complexed with soluble IgG/IgM D1.3
is shown in the right hand panel. responses. First, the same dependence on antigen affin-
(B) Presentation was monitored of TEL alone (TEL) or TEL plus ity was observed when different T cell hybridomas (dif-
soluble HyHEL10 IgG1 (TEL 1 IgG) as well as of HEL alone (HEL) fering in their sensitivity) were used for read-out. Sec-
or HEL plus soluble HyHEL10 IgG1 (TEL 1 IgG) by LK[D1.3] transfec-
ond, the proposal of threshold and ceiling values fortants.
antigen/BCR avidity is amply supported by experiments(C) Presentation of wild-type HEL alone (HEL) or plus soluble D1.3
in which we sought to enhance presentation by oligo-IgG1 (HEL1IgG) by LK[HyHEL10] transfectants was assayed to the
1E5 T cell hybridoma. (The curve obtained with HEL 1 IgM was merization of the variant lysozymes using soluble anti-
similar to that obtained with HEL 1 IgG.) bodies:oligomerization could lead to effective presenta-
tion of antigens that were otherwise poorly presented
because they were below the affinity threshold. How-
ever, with a tightly binding antigen, oligomerizationDiscussion
could not yield further enhancement since the affinity
ceiling had already been reached. A third line of supportDetectable BCR-mediated presentation and transmem-
brane signaling in the assays described here required comes from the fact that the affinity dependence noted
for presentation also held good in the signaling assays.the antigen/BCR interaction to have a minimum dissoci-
ation half-life of around 1 s (corresponding to a Ka of Finally, as discussed below, our conclusions are consis-
tent with in vivo experiments (Roost et al., 1995) and106 M21). The sensitivity of the assays to antigen concen-
tration then increased in parallel with antigen/BCR affin- are indeed in part anticipated in a commentary by Foote
and Eisen (1995).ity, being highly responsive to affinity changes when the
affinity was in the range 106±108 M21. However, at Ka The threshold Ka value of 106 M21 that we deduce for
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BCR triggering was obtained using monovalent antigen. the importance of kinetic considerations, at least in this
range of koff/Ka values. Intriguingly, the range of dissocia-We are not aware of in vivo experiments that reveal the
minimumaffinity needed to initiatean antibody response tion T1¤2 values in which presentation is very sensitive to
koff is the same as the time range in which antigen be-to a monovalent antigen. However, the affinities for free
hapten that have been reported for antibodies isolated comes internalized and targeted to MHC class II (David-
son et al., 1991). The results could therefore reflect aearly in the response topolyvalent hapten-proteinconju-
gates are in the 105±106 M21 range (Eisen and Siskind, selective advantage for antigen to remain associated
with BCR during intracellular trafficking.1964; Reth et al., 1978; Gearhart et al., 1981; Foote and
Milstein, 1991). Furthermore, the response to polyvalent Comparison of the mutant lysozymes revealed that,
for specific BCR-mediated presentation and signaling,hapten/protein conjugates might well be initiated using
BCRs that display even lower Kas for the free hapten a minimum binding strength of around Ka of 106 M21,
(dissociation T1¤2 of 1 s, as determined at 258C) was(e.g., see Jacob et al., 1993). The likely explanation for
the apparent discrepancy between the threshold Ka de- required. However, the mutant HELs all share a fast
kon (.106 M21s21), and we therefore suspect that theduced in our in vitro analysis of HEL-specific B cell
transfectants and the in vivo responses to polyvalent experiments reveal the minimum half-life of the antigen/
BCR complex compatible with triggering (i.e., the kinetichapten/carrier conjugates comes from the fact that one
is contrasting monovalent and polyvalent systems and threshold). In systems displaying a lower kon it may well
be that presentation is achieved at Ka values ,106 M21ignoring avidity effects: the true Ka of the BCR for the
complete polyvalent hapten/carrier conjugate (as op- with thermodynamic considerations ultimately determin-
ing the threshold.posed to the free hapten) is not known. In line with such
thinking, the affinity threshold for HEL presentation in With regard to the ceiling for affinity maturation, our
value of 1010 M21 is similar to the upper echelons ofour work could be lowered by oligomerizing the lyso-
zyme with high affinity, soluble antibody. Oligomeriza- affinities seen for monoclonal antibodies. Evidence sup-
porting the existence of such a ceiling in vivo comestion of the antigen by natural antibody may well play a
role in lowering the Ka threshold in vivo. It will be interest- from the work of Roost et al. (1995) who noted that the
antibodies elicited in the primary response to vesicularing to extend the in vitro studies of HEL presentation to
test whether potentiation is obtained with such natural stomatitis virus are of good affinity (presumably re-
flecting evolutionary selection for maintenance of theseantibody. Furthermore, antibody complexing of antigen
in vivo will not only serve to increase the avidity of the germline specificities) and that further maturation of the
affinity is not seen. Indeed, in a commentary on thisantigen/BCR interaction, the immune complexes may
trigger complement deposition thereby causing costim- work, Foote and Eisen (1995) proposed the existence
of a ceiling value to affinity maturation based on theulation of BCR signaling through recruitment of the
CD21/CD19 complex (Carter and Fearon, 1992). It will presumptions there must be a diffusion-limited ceiling
to kon together with it being difficult to envisage selectionbe worth extending the in vitro studies of BCR-mediated
signaling and presentation of the variant lysozymes to for dissociation half-lives longer than around 1 hr. This
gave a predicted ceiling Ka value in the order of 1010 M21,test the effect of complement recruitment.
From an analysis of MAbs isolated at various stages agreeing well with the ceiling observed in our assays. As
pointed out by Foote and Eisen, these analyses andof an anti-hapten response, it has been argued that
affinity maturation can be driven by both kinetic and experiments do not, of course, imply that antibodies
with Kas greater than 1010 M21 cannot be obtained; ratherthermodynamic parameters (Foote and Milstein, 1991).
In our work, the mutant HELs largely differ from each that there is unlikely to be actual selection in favor of
mutations that take affinities beyond this value.other in terms of their rate of dissociation from BCR
(rather than kon), a finding that parallels observations One of the many aspects in which our in vitro assays
do not mimic in vivo affinity maturation is that, whereasmade with site-directed mutants inother protein±protein
interaction systems (Cunningham and Wells, 1993). The in vivo maturation presumably occurs by competing dif-
ferent B cell clones, in this work we analyze the perfor-question arises as to whether the dependence of pre-
sentation efficiency on koff reflects the importance of mance of individual clones in isolation. The issue there-
fore arises as to whether competition for the ability tokinetic considerations or whether the effect is achieved
because of consequent changes in Ka (thermodynamic scavenge small amounts of antigen could allow an affin-
ity to be selected beyond the ceiling determined here.considerations). Clearly, the relative importance of ki-
netic and thermodynamic considerations could well de- However, if the BCRs in question have affinities for anti-
gen in the range of 1010 M21 and if the kon has reachedpend on the particular koff/Ka values analyzed. One ap-
proach to the question is to compare presentation by a diffusion-limited maximum (around 106 M21s1) then the
half-life of the antigen BCR complex is likely to be in theantigen/BCR pairs that share the same Ka but differ in
their absolute kon and koff values. Whilst considerable order of several hours. There must therefore be doubt as
to whether there is time for equilibration to occur suchcaution must be exercised in comparing presentation
by transfectants carrying different BCRs (because, for that a higher affinity antibody could scavenge its in-
creased share of antigen from a competitor with Ka ofexample, of potential epitope protection effects [Watts
and Lanzavecchia, 1993]), it is notable that wild-type 1010 M21.
The dependence of the B cell response on the kineticsHEL is significantly better presented through the D1.3
BCR (Ka 3 3 108 M21; T1¤2 dissociation 3.8 min) than is of antigen interaction contrasts with the likely situation
in T cells. Although both BCR and TCR can both respondthe [R21,D101,G102,N103] mutant through the HyHEL10 BCR
(Ka 5 3 108 M21; T1¤2 dissociation 1.4 min). This points to to ligand interactions that have half-lives in the order of
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In the oligomerization experiments, lysozyme at the appropriateseconds (this work and Matsui et al., 1991; Weber et
concentration for each assay point was preincubated with 2 mgal., 1992; Sykulev et al., 1994), it has been proposed
of soluble HyHEL10, D1.3, or a recombinant IgM-version of D1.3that the sensitivity of T cells to small amounts of antigen
(prepared from NS0 cells transfected with appropriate plasmid con-
is achieved by serial triggering such that the T cell re- structs) for 1 hr prior to addition to the presentation assay.
sponse actually decreases if the dissociation half-life of Signaling assays were performed by incubating 105 cells of the
appropriate A20/BCR transfectant in medium (200 ml) with the indi-TCR/MHC-peptide interaction is increased substantially
cated concentration of lysozyme for 24 hr and measuring IL-2 pro-above the triggering threshold (Valitutti and Lanzavec-
duction as described above.chia, 1997). However, in the humoral arm of the immune
system, where the purpose is ultimately to produce se-
Measurements of Affinity and Binding Kineticsrum antibody (rather than cells) that will bind and neutral-
Affinity measurements of the lysozyme/D1.3 interaction were per-ize very small amounts of antigen, serial triggering is
formed using fluorescence quench as described by Foote and Win-
not an option. The selection is therefore for improved ter (1992) and by the ELISA method of Friguet (Friguet et al., 1985).
bindingÐup to the intrinsic affinity ceiling of the selec- Relative affinities (Karel values) were obtained by competition ELISA
tion system. in which various concentrations of mutant lysozymes were used to
compete the binding of biotinylated-HEL to the appropriate MAb
immobilized on the plate.Experimental Procedures
Kinetic constants for the interaction between soluble lysozymes
and immobilized antibodies were measured by surface plasmonB Cell Lines and Transfectants
resonance using the Biacore. Antibodies were coupled to the dex-Hybridomas expressing D1.3 and F10 anti-HEL and E5.2 anti-D1.3-
tran of a CM5 sensor chip (Pharmacia Biosensor) using standardId MAbs were provided by R. Poljak; the HyHEL5 and HyHEL10 lines
NHS-EDC chemistry (JoÈnsson et al., 1991). Binding assays werewere provided by S. J. Smith-Gill. The mouse B cell lymphomas A20
performed in HEPES-buffered saline (pH 7.4) (Pharmacia). koff values(IgG2a,k; H2d) and LK35.2 (IgG2a,k; H2kxd) are described in Kim et
were obtained by direct interpolation of the signal decay using BIA-al., 1979, and Kappler et al., 1982, respectively.
evaluation 2.1 software (Pharmacia).B cell transfectants expressing HEL-specific BCRs were estab-
lished by electroporation. The heavy chain construct is based on a
AcknowledgmentspbG-mm derivative (which drives expression of the mm but not ms
isoform of mouse m H chain (Williams et al., 1990) from which the
We thank Roberto Poljak, Sandra Smith-Gill, and Lucio Adorini forVH segment can be excised as a PstI-BstEII fragment (Teh and
generous provision of cell lines; Roger Williams for invaluable assis-Neuberger, 1997). The VH regions of D1.3 and HyHEL10 were PCR-
tance with computer graphics; Petra Budde, Amine Khamlichi, andamplified with appropriate oligonucleotides to yield a PstI site span-
Gareth Williams for help in constructing some of the transfectants;ning VH codon 4/5 and a BstEII site spanning codons 112/113 and
and Amine Khamlichi, Yih-Miin Teh, Varuna Aluvihare, Perry Kirk-inserted into the pbG-mm-based vector. The k chain expression con-
ham, Mairi Stewart, CeÂsar Milstein, and Dario Neri for advice andstructs were assembled by inserting PCR-amplified Vk regions of
discussions. F. D. B. is supported by an EMBO fellowship.D1.3 or HyHEL10 into a previously-described k vector (Teh and
Neuberger, 1997) in which the Vk segment (containing a SacI site
at Vk codon position 3/4 and an XhoI site at position 104/105 in Jk) Received March 13, 1998; revised May 14, 1998.
is linked to a rat Ck exon.
Transfectants were established by electroporation and cloned by
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